As one of the world's leading universities, the University of British Columbia creates an exceptional learning environment that fosters global citizenship, advances a civil and sustainable society, and supports outstanding research to serve the people of British Columbia, Canada and the world.

Dr. Hoeppli studied how Regulatory T cells, a type of white blood cell, could be used like a drug to prevent graft rejection after organ transplantation. She found that these cells can be modified during cell culture to increase their effectiveness as a drug. Her research contributes towards improving the success of organ transplantation.

A randomly-selected Doctoral citation each day: today from the Doctor of Philosophy in Experimental Medicine (PhD) - graduated in 2018